Product Details

Verythro Capsules meet British Pharmacopoeia (BP) standards for the treatment of bacterial infections. Specifically, each capsule delivers Erythromycin BP at 500mg. As a result, it offers reliable macrolide antibiotic coverage, particularly for patients who cannot tolerate penicillin-based therapy.

The capsules contain:

• Erythromycin BP (500mg) – A macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Consequently, it exerts bacteriostatic activity against a range of gram-positive organisms and certain atypical pathogens.

Physicians prescribe Verythro for the treatment of respiratory tract infections, skin and soft tissue infections, and certain sexually transmitted infections, particularly in patients with penicillin allergy. In addition, its established safety profile makes it a valuable alternative across a wide range of clinical presentations. Because of this profile, Verythro suits general practice, paediatric, and hospital settings managing bacterial infections in penicillin-sensitive patients.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the oral capsule format supports easy, convenient dosing
• Furthermore, each capsule delivers precise, validated dosage accuracy at 500mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, blister packaging protects capsule integrity against light
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies